M M Farley

Summary

Affiliation: Emory University
Country: USA

Publications

  1. ncbi request reprint Group B streptococcal disease in nonpregnant adults
    M M Farley
    Emory University School of Medicine and The Atlanta Veterans Affairs Medical Center, 1670 Clairmont Road, Atlanta, GA 30333, USA
    Clin Infect Dis 33:556-61. 2001
  2. doi request reprint 2009 H1N1 influenza: a twenty-first century pandemic with roots in the early twentieth century
    Monica M Farley
    Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine and the Atlanta VA Medical Center, Atlanta, Georgia, USA
    Am J Med Sci 340:202-8. 2010
  3. ncbi request reprint Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    A E Fiore
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 30:71-7. 2000
  4. ncbi request reprint The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment
    K Gay
    Departments of Medicine and of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
    J Infect Dis 182:1417-24. 2000
  5. pmc Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus
    D J Livorsi
    Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA
    Antimicrob Agents Chemother 56:4474-7. 2012
  6. ncbi request reprint Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
    S J Schrag
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 342:15-20. 2000
  7. ncbi request reprint Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    R F Breiman
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
    Arch Intern Med 160:2633-8. 2000
  8. ncbi request reprint Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
    J F Moroney
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:797-805. 2001
  9. ncbi request reprint Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine
    W C Albrich
    Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA
    Clin Infect Dis 44:1569-76. 2007

Collaborators

  • A Schuchat
  • L H Harrison
  • Jan Evans Patterson
  • J H Jorgensen
  • A E Fiore
  • K Gay
  • D J Livorsi
  • W C Albrich
  • R F Breiman
  • Y F Wang
  • S W Satola
  • R Jerris
  • E Crispell
  • E M Burd
  • J F Moroney
  • A L Reingold
  • S J Schrag
  • B Schmotzer
  • W Baughman
  • M Kolczak
  • R R Facklam
  • M Phelan
  • M S Cetron
  • M A Phelan
  • L B Lefkowitz
  • R Danila
  • J L Hadler
  • D W Keller
  • S Zywicki
  • D S Stephens
  • D H Sniadack
  • D Rimland
  • P R Cieslak

Detail Information

Publications9

  1. ncbi request reprint Group B streptococcal disease in nonpregnant adults
    M M Farley
    Emory University School of Medicine and The Atlanta Veterans Affairs Medical Center, 1670 Clairmont Road, Atlanta, GA 30333, USA
    Clin Infect Dis 33:556-61. 2001
    ..The role of antibodies in protection against GBS disease in nonpregnant adults is unresolved. However, the immunogenicity of GBS vaccines being developed for prevention of neonatal disease should be assessed for adults who are at risk...
  2. doi request reprint 2009 H1N1 influenza: a twenty-first century pandemic with roots in the early twentieth century
    Monica M Farley
    Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine and the Atlanta VA Medical Center, Atlanta, Georgia, USA
    Am J Med Sci 340:202-8. 2010
    ..The 2009 H1N1 pandemic highlights the need for modernization of influenza vaccines, improved diagnostics and more rigorous evaluation of mitigation strategies...
  3. ncbi request reprint Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
    A E Fiore
    Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 30:71-7. 2000
    ..Empirical use of vancomycin, current prevalence of drug-resistant S. pneumoniae, and degree of nonsusceptibility to cefotaxime may have influenced these findings...
  4. ncbi request reprint The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment
    K Gay
    Departments of Medicine and of Microbiology and Immunology, Emory University School of Medicine, Atlanta, Georgia, USA
    J Infect Dis 182:1417-24. 2000
    ..Dissemination of the mefE determinant accounted for the rapid increase in the rate of macrolide resistance in our S. pneumoniae population...
  5. pmc Prevalence of blaZ gene types and the inoculum effect with cefazolin among bloodstream isolates of methicillin-susceptible Staphylococcus aureus
    D J Livorsi
    Division of Infectious Diseases, Emory University School of Medicine, Atlanta, Georgia, USA
    Antimicrob Agents Chemother 56:4474-7. 2012
    ..The efficacy of cefazolin in the presence of the inoculum effect requires further study...
  6. ncbi request reprint Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
    S J Schrag
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Disease, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    N Engl J Med 342:15-20. 2000
    ..To assess the effects of the preventive efforts, we analyzed trends in the incidence of group B streptococcal disease from 1993 to 1998...
  7. ncbi request reprint Evaluation of effectiveness of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients
    R F Breiman
    Centers for Disease Control and Prevention, 1600 Clifton Rd, MS C 12, Atlanta, GA 30333, USA
    Arch Intern Med 160:2633-8. 2000
    ..We conducted a retrospective case-control study to evaluate effectiveness of pneumococcal vaccine against invasive disease among adults with human immunodeficiency virus (HIV) infection in San Francisco, Calif, and Atlanta, Ga...
  8. ncbi request reprint Clinical outcomes of bacteremic pneumococcal pneumonia in the era of antibiotic resistance
    J F Moroney
    Respiratory Diseases Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30333, USA
    Clin Infect Dis 33:797-805. 2001
    ..Factors other than resistance, such as severity of illness at presentation and advance directive status ("do not resuscitate" orders), appear to have a stronger influence on pneumococcal pneumonia outcomes...
  9. ncbi request reprint Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine
    W C Albrich
    Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA
    Clin Infect Dis 44:1569-76. 2007
    ..The rate of invasive pneumococcal disease (IPD) has decreased among both immunized children and nonimmunized adults since the licensure of a heptavalent pneumococcal conjugate vaccine (PCV7) for use in infants in the United States in 2000...